Works by Ferrannini, Ele
Results: 293
Effects of Hypertriglyceridemia With or Without NEFA Elevation on β-cell Function and Insulin Clearance and Sensitivity.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. e667, doi. 10.1210/clinem/dgae276
- By:
- Publication type:
- Article
IgG N-Glycosylation Is Altered in Coronary Artery Disease.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 375, doi. 10.3390/biom13020375
- By:
- Publication type:
- Article
Insulin resistance versus β-cell dysfunction in the pathogenesis of type 2 diabetes.
- Published in:
- Current Diabetes Reports, 2009, v. 9, n. 3, p. 188, doi. 10.1007/s11892-009-0031-8
- By:
- Publication type:
- Article
Age, Renal Dysfunction, Cardiovascular Disease, and Antihyperglycemic Treatment in Type 2 Diabetes Mellitus: Findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
- Published in:
- Journal of the American Geriatrics Society, 2013, v. 61, n. 8, p. 1253, doi. 10.1111/jgs.12381
- By:
- Publication type:
- Article
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.
- Published in:
- Diabetes Care, 2024, v. 47, n. 9, p. 1630, doi. 10.2337/dc24-0470
- By:
- Publication type:
- Article
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors.
- Published in:
- Diabetes Care, 2024, v. 47, n. 2, p. 246, doi. 10.2337/dc23-0870
- By:
- Publication type:
- Article
Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS).
- Published in:
- 2022
- By:
- Publication type:
- journal article
New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Response to Comment on Ferrannini and Rosenstock. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641-646.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Erratum. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2031;44:641-646.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843-851.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial.
- Published in:
- 2019
- By:
- Publication type:
- Letter
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial.
- Published in:
- Diabetes Care, 2018, v. 41, n. 2, p. 356, doi. 10.2337/dc17-1096
- By:
- Publication type:
- Article
Diabetes Research and Care Through the Ages.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Response to Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114.
- Published in:
- 2016
- By:
- Publication type:
- Letter
CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Response to Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Response to Comment on Rosenstock and Ferrannini. Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors. Diabetes Care 2015;38:1638-1642.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.
- Published in:
- 2016
- By:
- Publication type:
- journal article
CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
α-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired Glucose Tolerance.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Of microbes and men.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition.
- Published in:
- Diabetes Care, 2015, v. 38, n. 9, p. 1730, doi. 10.2337/dc15-0355
- By:
- Publication type:
- Article
Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach.
- Published in:
- Diabetes Care, 2015, v. 38, n. 1, p. 140, doi. 10.2337/dc14-2441
- By:
- Publication type:
- Article
Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity.
- Published in:
- Diabetes Care, 2013, v. 36, n. 12, p. 4125, doi. 10.2337/dc13-0682
- By:
- Publication type:
- Article
Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin.
- Published in:
- Diabetes Care, 2013, v. 36, n. 12, p. 4015, doi. 10.2337/dc13-0663
- By:
- Publication type:
- Article
Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Personalized Management of Hyperglycemia in Type 2 Diabetes.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
Renal glucose handling: impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Renal Glucose Handling.
- Published in:
- Diabetes Care, 2013, v. 36, n. 5, p. 1260, doi. 10.2337/dc12-1503
- By:
- Publication type:
- Article
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- 2012
- By:
- Publication type:
- journal article
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach.
- Published in:
- Diabetes Care, 2012, v. 35, n. 6, p. 1364, doi. 10.2337/dc12-0413
- By:
- Publication type:
- Article
Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?
- Published in:
- Diabetes Care, 2011, v. 34, n. 6, p. 1424, doi. 10.2337/dc11-0447
- By:
- Publication type:
- Article
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise.
- Published in:
- Diabetes Care, 2010, v. 33, n. 10, p. 2217, doi. 10.2337/dc10-0612
- By:
- Publication type:
- Article
Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy.
- Published in:
- Diabetes Care, 2010, v. 33, n. 4, p. 730, doi. 10.2337/dc09-1867
- By:
- Publication type:
- Article